TQVAX Fees and Costs — T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund, Advisor Class
Data updated: 2026-08-27
The net expense ratio is 0.99%: a 0.48% management fee, a 0.25% 12b-1 fee plus 1.60% other expenses, less a 1.34% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $13K in broker commissions, 0.0208% of average net assets, and portfolio turnover was 88%.
TQVAX Fees and Expenses
Annual operating expenses and sales charges of TQVAX. Prospectus, as of December 31, 2024.
| Annual operating expenses | |
|---|---|
| Management fee | 0.48% |
| 12b-1 fee | 0.25% |
| Other expenses | 1.60% |
| Gross expense ratio | 2.33% |
| Fee waiver | −1.34% |
| Net expense ratio | 0.99% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
TQVAX Costs Over Time
On $10,000 invested in TQVAX, assuming 5% a year before costs, total costs come to $632 over 5 years, cutting the return by 1.06% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.99%) | $104 | $324 | $562 |
| Trading costs (broker commissions) | $2 | $7 | $12 |
| Lost growth on money paid in costs | $0 | $16 | $58 |
| Total costs | $106 | $348 | $632 |
| Value after costs | $10,394 | $11,229 | $12,131 |
| Impact on return, per year | 1.06% | 1.06% | 1.06% |
TQVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0208%
- Total broker commissions: $13K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 88%
- Securities on loan, average value: $324K
- Net income from securities lending: $2K (0.003% of average net assets)
TQVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| UBS AG | $2K | 21.09% |
| BOFA SECURITIES, INC. | $1K | 11.95% |
| MORGAN STANLEY & CO. LLC | $1K | 10.51% |
| Jane Street Execution Services, LLC | $1K | 10.07% |
| TD Securities Ltd. | $890 | 8.78% |
| CITADEL SECURITIES INSTITUTIONAL LLC | $877 | 8.65% |
| J.P. MORGAN SECURITIES LLC | $805 | 7.94% |
| Virtu ITG Hong Kong Limited | $786 | 7.75% |
| BERNSTEIN INSTITUTIONAL SERVICES LLC | $687 | 6.78% |
| Citigroup Inc. | $657 | 6.48% |
T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| TQVIX | I Class | 0.53% | — |
| TQMVX | T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund | 0.72% | — |
| TQVAX | Advisor Class | 0.99% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.